Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

QUANTUM GRAPHITE LIMITED Capital/Financing Update 2018

Sep 25, 2018

65646_rns_2018-09-25_5f3d54f1-04ef-44f2-8bae-9db962268484.pdf

Capital/Financing Update

Open in viewer

Opens in your device viewer

MARKET RELEASE For Immediate Release 25 September 2018

Capital Structure (as announced on 3 September 2018)

In anticipation of the reinstatement for quotation of the Company's securities, the Company's capital structure as announced on 3 September 2018, is again set out in this announcement and includes the following:

(a) the Top 20 Investors Report;

(b) the Investor Ranges Report;

(c) the terms of issue of the options; and

(d) the Appendix 3B.

Sal Catalano Company Secretary Quantum Graphite Limited e: [email protected]

TOP 20 INVESTORS REPORT

INVESTOR SHARES BALANCE
CHIMAERA CAPITAL LIMITED 1,776,339,123
ZIZIPHUS PTY LTD 419,039,273
SELSO PTY LTD 331,553,268
INSYNC INVESTMENTS PTY LTD 325,470,262
LYCOPODIUM LIMITED 256,030,821
MICHAEL JAMES MADDOX 198,367,579
ACN 112 940 057 PTY LTD 194,364,157
GOLDER ASSOCIATES PTY LTD 169,084,069
G & N LORD SUPERANNUATION PTY LTD 164,770,131
ASYMMETRIC CREDIT PARTNERS PTY LTD 161,970,131
RUSSELL HOWARD PTY LTD 161,970,131
FUDDY PTY LTD 155,605,664
CHIMAERA CAPITAL LIMITED 150,000,000
PETER FAULKNER INVESTMENTS PTY LTD 143,654,232
NEXT AUSTRALIA PTY LTD 143,600,943
VALENCE INDUSTRIES SERVICES PTY LTD <(IN LIQUIDATION) A/C> 115,388,438
GETCO PTY LTD 99,183,789
MR IAN DAVID PATTISON + MS KATHERINE MARGARET FORREST <sylvan f<="" s="" td="">
A/C> 96,680,306
MR DAVID JOHN HEBBERMAN + MS JOSEPHINE NORA HALL <david hebberman<="" td="">
FAM S/F A/C> 93,312,422
HATCH EGGS PTY LTD 81,697,218
TUKE INVESTMENTS PTY LTD 80,266,745
INVESTOR OPTIONS BALANCE
CHIMAERA CAPITAL LIMITED 1,000,000,000

INVESTOR RANGES REPORT

RANGE NO. INVESTORS NO. SHARES % ISSUED CAPITAL
1 to 1000 173 69,337 0.00%
1001 to 5000 1,268 4,029,158 0.05%
5001 to 10000 761 6,097,765 0.08%
10001 to 100000 1,574 53,258,177 0.71%
100001 and Over 461 7,423,333,995 99.15%
Total 4,237 7,486,788,432 100.00%

TERMS OF ISSUE OF OPTIONS

  • (a) The options shall have a term of 5 years and can be exercised at any time until their expiry date upon the fifth anniversary of their issue.
  • (b) The exercise price of the options shall be nil. The options shall be allocated on the basis that their value is \$0.00252 per option.
  • (c) Should the exercise of any of the options result in the relevant shareholder increasing its interest in the Company beyond 20%, the exercise of those options will require shareholder approval (unless the exercise is otherwise permitted under any applicable law).
  • (d) In the event that the shareholder approval referred to in paragraph (c) is not obtained, the option holder shall be entitled to receive payment of an amount equal to the notional principle amount (calculated as the product of the option value referred in paragraph (b) and the number of options for which approval has been sought), plus compound interest at the rate of 20% per annum.

Rule 2.7, 3.10.3, 3.10.4, 3.10.5

Appendix 3B

New issue announcement, application for quotation of additional securities and agreement

Information or documents not available now must be given to ASX as soon as available. Information and documents given to ASX become ASX's property and may be made public.

Introduced 01/07/96 Origin: Appendix 5 Amended 01/07/98, 01/09/99, 01/07/00, 30/09/01, 11/03/02, 01/01/03, 24/10/05, 01/08/12, 04/03/13

Name of entity

Quantum Graphite Limited

ABN

41 008 101 979

We (the entity) give ASX the following information.

Part 1 - All issues

You must complete the relevant sections (attach sheets if there is not enough space).

1 +Class of +securities issued or to
be issued
Ordinary Shares
2 Number of +securities issued or to
be issued (if known) or maximum
number which may be issued
(a)
177,243,000
(b)
108,000,000
Total - 285,243,000
3 Principal terms of the +securities
(e.g. if options, exercise price and
expiry date; if partly paid
+securities, the amount
outstanding and due dates for
payment; if +convertible
securities, the conversion price
and dates for conversion)
Ordinary Shares: Fully paid

+ See chapter 19 for defined terms.

4 Do the +securities rank equally in
all respects from the +issue date
with an existing +class of quoted
+securities?
Ordinary Shares: Yes
If the additional +securities do not
rank equally, please state:

the date from which they do

the extent to which they
participate for the next
dividend, (in the case of a
trust, distribution) or interest
payment

the extent to which they do not
rank equally, other than in
relation to the next dividend,
distribution or interest
payment
5 Issue price or consideration (a)
Issued pursuant to shareholder resolutions passed
at the Annual General Meeting of shareholders on
22 June 2018.
(b)
Directors' remuneration as approved at the Annual
General Meetings of shareholders on 18 December
2017 and 22 June 2018.
6 Purpose of the issue
(If issued as consideration for the
acquisition of assets, clearly
identify those assets)
See sections 5(a) and 5(b) above.
6a Is the entity an +eligible entity
that has obtained security holder
approval under rule 7.1A?
If Yes, complete sections 6b – 6h
in relation to the +securities the
subject of this Appendix 3B, and
comply with section 6i
Yes
6b The date the security holder
resolution under rule 7.1A was
passed
22 June 2018
6c Number of +securities issued
without security holder approval
under rule 7.1
Nil
6d Number of +securities issued with
security holder approval under
rule 7.1A
Nil
  • 6f Number of +securities issued under an exception in rule 7.2
  • 6g If +securities issued under rule 7.1A, was issue price at least 75% of 15-day VWAP as calculated under rule 7.1A.3? Include the +issue date and both values. Include the source of the VWAP calculation.
  • 6h If +securities were issued under rule 7.1A for non-cash consideration, state date on which valuation of consideration was released to ASX Market Announcements
  • 6i Calculate the entity's remaining issue capacity under rule 7.1 and rule 7.1A – complete Annexure 1 and release to ASX Market Announcements
  • 7 +Issue dates

Note: The issue date may be prescribed by ASX (refer to the definition of issue date in rule 19.12). For example, the issue date for a pro rata entitlement issue must comply with the applicable timetable in Appendix 7A.

Cross reference: item 33 of Appendix 3B.

Not applicable

Not applicable

Not applicable

Not applicable

The entity's issue capacity under rule 7.1 and rule 7.1A is unaffected by the issue described above.

28 August 2018

Number +Class
8 Number and +class of all
+securities quoted on ASX
(including the +securities in
section 2 if applicable)
199,016,214 Ordinary

9 Number and +class of all +securities not quoted on ASX (including the +securities in section 2 if applicable)

Number +Class
7,287,772,218 Ordinary
1,000,000,000 Options to acquire
ordinary shares, exercise
price \$0.00, expiry date
20 July 2023

10 Dividend policy (in the case of a trust, distribution policy) on the increased capital (interests)

Part 2 - Pro rata issue

11 Is security holder approval required?
12 Is the issue renounceable or non
renounceable?
13 Ratio in which the +securities will be
offered
14 +Class of +securities to which the offer
relates
15 +Record date to determine
entitlements
16 Will holdings on different registers (or
subregisters) be aggregated for
calculating entitlements?
17 Policy for deciding entitlements in
relation to fractions
18 Names of countries in which the entity
has security holders who will not be
sent new offer documents
Note: Security holders must be told how their
entitlements are to be dealt with.
Cross reference: rule 7.7.
19 Closing date for receipt of acceptances
or renunciations
20 Names of any underwriters
21 Amount of any underwriting fee or
commission
22 Names of any brokers to the issue
23 Fee or commission payable to the
broker to the issue
24 Amount of any handling fee payable to
brokers who lodge acceptances or
renunciations on behalf of security
holders
25 If the issue is contingent on security
holders' approval, the date of the
meeting
26 Date entitlement and acceptance form
and offer documents will be sent to
persons entitled
27 If the entity has issued options, and
the terms entitle option holders to
participate on exercise, the date on
which notices will be sent to option
holders
28 Date rights trading will begin (if
applicable)
29 Date
rights
trading
will
end
(if
applicable)
30 How do security holders sell their
entitlements in full through a broker?
31 How do security holders sell part of
their entitlements through a broker

and accept for the balance?

  • 32 How do security holders dispose of their entitlements (except by sale through a broker)?
  • 33 +Issue date

Part 3 - Quotation of securities

You need only complete this section if you are applying for quotation of securities

  • 34 Type of +securities (tick one)
  • (a) +Securities described in Part 1

(b) All other +securities

Example: restricted securities at the end of the escrowed period, partly paid securities that become fully paid, employee incentive share securities when restriction ends, securities issued on expiry or conversion of convertible securities

Entities that have ticked box 34(a)

Additional securities forming a new class of securities

Tick to indicate you are providing the information or documents

35 If the +securities are +equity securities, the names of the 20 largest holders of the
additional +securities, and the number and percentage of additional +securities
held by those holders
36 If the +securities are +equity securities, a distribution schedule of the additional
+securities setting out the number of holders in the categories
1 - 1,000
1,001 - 5,000
5,001 - 10,000
10,001 - 100,000
100,001 and over
37 A copy of any trust deed for the additional +securities

+ See chapter 19 for defined terms.

Entities that have ticked box 34(b)

  • 38 Number of +securities for which +quotation is sought
  • 39 +Class of +securities for which quotation is sought
  • 40 Do the +securities rank equally in all respects from the +issue date with an existing +class of quoted +securities?

If the additional +securities do not rank equally, please state:

  • the date from which they do
  • the extent to which they participate for the next dividend, (in the case of a trust, distribution) or interest payment
  • the extent to which they do not rank equally, other than in relation to the next dividend, distribution or interest payment
  • 41 Reason for request for quotation now

Example: In the case of restricted securities, end of restriction period

(if issued upon conversion of another +security, clearly identify that other +security)

42 Number and +class of all +securities quoted on ASX (including the +securities in clause 38)

Number +Class

Quotation agreement

1 +Quotation of our additional +securities is in ASX's absolute discretion. ASX may quote the +securities on any conditions it decides.

+ See chapter 19 for defined terms.

  • 2 We warrant the following to ASX.
  • The issue of the +securities to be quoted complies with the law and is not for an illegal purpose.
  • There is no reason why those +securities should not be granted +quotation.
  • An offer of the +securities for sale within 12 months after their issue will not require disclosure under section 707(3) or section 1012C(6) of the Corporations Act.

Note: An entity may need to obtain appropriate warranties from subscribers for the securities in order to be able to give this warranty

  • Section 724 or section 1016E of the Corporations Act does not apply to any applications received by us in relation to any +securities to be quoted and that noone has any right to return any +securities to be quoted under sections 737, 738 or 1016F of the Corporations Act at the time that we request that the +securities be quoted.
  • If we are a trust, we warrant that no person has the right to return the +securities to be quoted under section 1019B of the Corporations Act at the time that we request that the +securities be quoted.
  • 3 We will indemnify ASX to the fullest extent permitted by law in respect of any claim, action or expense arising from or connected with any breach of the warranties in this agreement.
  • 4 We give ASX the information and documents required by this form. If any information or document is not available now, we will give it to ASX before +quotation of the +securities begins. We acknowledge that ASX is relying on the information and documents. We warrant that they are (will be) true and complete.

Sign here: ............................................................ Date: 29 August 2018 (Director/Company secretary)

Print name: SAL CATALANO

== == == == ==

+ See chapter 19 for defined terms.

Appendix 3B – Annexure 1

Calculation of placement capacity under rule 7.1 and rule 7.1A for eligible entities

Introduced 01/08/12 Amended 04/03/13

Part 1

Rule 7.1 – Issues exceeding 15% of capital
Step 1: Calculate "A", the base figure from which the placement
capacity is calculated
Add the following:
Number of fully paid +ordinary securities

issued in that 12 month period under an
exception in rule 7.2
Number of fully paid +ordinary securities

issued in that 12 month period with
shareholder approval
Number of partly paid +ordinary

securities that became fully paid in that
12 month period
Note:

Include only ordinary securities here –
other classes of equity securities cannot
be added

Include here (if applicable) the securities
the subject of the Appendix 3B to which
this form is annexed

It may be useful to set out issues of
securities on different dates as separate
line items
Subtract the number of fully paid +ordinary
securities cancelled during that 12 month
period
"A"

+ See chapter 19 for defined terms.

Step 2: Calculate 15% of "A"
"B" 0.15
[Note: this value cannot be changed]
Multiply "A" by 0.15
Step 3: Calculate "C", the amount of placement capacity under rule 7.1
that has already been used
Insert number of +equity securities issued or
agreed to be issued in that 12 month period
not counting those issued:

Under an exception in rule 7.2

Under rule 7.1A

With security holder approval under rule
7.1 or rule 7.4
Note:

This applies to equity securities, unless
specifically excluded – not just ordinary
securities

Include here (if applicable) the securities
the subject of the Appendix 3B to which
this form is annexed

It may be useful to set out issues of
securities on different dates as separate
line items
"C"
Step 4: Subtract "C" from ["A" x "B"] to calculate remaining placement
capacity under rule 7.1
"A" x 0.15
Note: number must be same as shown in
Step 2
Subtract "C"
Note: number must be same as shown in
Step 3
Total ["A" x 0.15] – "C"
[Note: this is the remaining placement
capacity under rule 7.1]

+ See chapter 19 for defined terms.

Part 2

Rule 7.1A – Additional placement capacity for eligible entities
Step 1: Calculate "A", the base figure from which the placement
capacity is calculated
"A"
Note: number must be same as shown in
Step 1 of Part 1
Step 2: Calculate 10% of "A"
"D" 0.10
Note: this value cannot be changed
Multiply "A" by 0.10
Step 3: Calculate "E", the amount of placement capacity under rule
7.1A that has already been used
Insert number of +equity securities issued or
agreed to be issued in that 12-month period
under rule 7.1A
Notes:

This applies to equity securities – not just
ordinary securities

Include here – if applicable – the
securities the subject of the Appendix 3B
to which this form is annexed

Do not include equity securities issued
under rule 7.1 (they must be dealt with in
Part 1), or for which specific security
holder approval has been obtained

It may be useful to set out issues of
securities on different dates as separate
line items
"E"

+ See chapter 19 for defined terms.

Step 4: Subtract "E" from ["A" x "D"] to calculate remaining placement
capacity under rule 7.1A
"A" x 0.10
Note: number must be same as shown in
Step 2
Subtract "E"
Note: number must be same as shown in
Step 3
Total ["A" x 0.10] – "E"
Note: this is the remaining placement
capacity under rule 7.1A

+ See chapter 19 for defined terms.